EUVIMEDEUVIMED entdecken
Crossref

Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk

Christos Savvidis, Costas Thomopoulos, Ioannis Ilias

World Journal of Experimental Medicine · 10.06.2026

DOI: 10.5493/wjem.120754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Experimental Medicine, online erschienen am 10.06.2026. Verfasst von Christos Savvidis und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Savvidis, C., Thomopoulos, C., & Ilias, I. (2026). Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk. World Journal of Experimental Medicine. https://doi.org/10.5493/wjem.120754

Vancouver

Savvidis C, Thomopoulos C, Ilias I. Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk. World Journal of Experimental Medicine. 2026. doi:10.5493/wjem.120754

BibTeX
@article{Savvidis2026,
  author = {Savvidis, Christos and Thomopoulos, Costas and Ilias, Ioannis},
  title = {Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk},
  journal = {World Journal of Experimental Medicine},
  year = {2026},
  doi = {10.5493/wjem.120754}
}
Kostenlos starten →